Last reviewed · How we verify
TRK-100STP high dose — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
TRK-100STP high dose (TRK-100STP high dose) — Toray Industries, Inc.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TRK-100STP high dose TARGET | TRK-100STP high dose | Toray Industries, Inc | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TRK-100STP high dose CI watch — RSS
- TRK-100STP high dose CI watch — Atom
- TRK-100STP high dose CI watch — JSON
- TRK-100STP high dose alone — RSS
Cite this brief
Drug Landscape (2026). TRK-100STP high dose — Competitive Intelligence Brief. https://druglandscape.com/ci/trk-100stp-high-dose. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab